Armani used his will to force the sale he refused in life — and who may buy

Giorgio Armani built the last big independent name in Italian fashion — and spent fifty years refusing to sell it, outlasting the sales of Gucci, Versace and Ferragamo's listing. He died on 4 September 2025 at 91, with no children and, unusually for a house of its size, no succession process beyond a foundation he had created in 2016.

The business will, deposited with Italian tax authorities and published by La Repubblica days later, was the succession plan. It split control: 40% to Pantaleo 'Leo' Dell'Orco, his companion and head of menswear; 15% each to Silvana Armani, who runs womenswear, and nephew Andrea Camerana; and 30% to the Armani Foundation. Armani also left his 2.5% holding in EssilorLuxottica — worth about €2.5 billion — 40% to Dell'Orco and 60% to the family.

Then the will did what the founder never would: it ordered a transaction. The heirs were instructed to sell a 15% stake within 18 months, with priority to LVMH, L'Oréal and EssilorLuxottica, followed by an additional 30% to 54.9% to the same buyer three to five years after his death. If no sale happened, the group should go public. EssilorLuxottica immediately said it would 'carefully assess' the prospect, citing deep existing ties — Armani already licensed eyewear to it.

A year on, the machine was running as designed but slowly: Reuters reported the initial 15% sale might slip past the will's March 2027 deadline, since its timing is not binding and best terms take precedence — while CEO Giuseppe Marsocci told the foundation board that group sales in early 2026 fell 7.5% in wholesale, a reminder of why the founder's clock matters.

An orderly, documented succession: control split between his collaborator, two heirs and a foundation, with EssilorLuxottica saying it would consider buying

Armani had no heir equal to running the empire, so splitting control among his closest collaborator, the design heirs and a foundation preserved continuity without pretending any one of them was him.

Naming LVMH, L'Oréal and EssilorLuxottica as the permitted buyers prevented a distressed or reputationally damaging sale to a stranger.

Sequencing 15% first, then up to 54.9%, let the new owners prove themselves before control changed — a staged exit rather than a cliff.

The IPO fallback stopped heirs from holding the company hostage: if they could not transact, markets would set the value instead.

Making the foundation a 30% shareholder gave the brand's identity a guardian with a financial veto over a complete takeover.

A founder who cannot choose a buyer in life can constrain the choice in death. A will can be a governance tool: it sets the clock, names the buyers, and forces heirs to transact rather than fight.

By August 2026 the process was under way: Rothschild banker and foundation director Irving Bellotti told an April board meeting that sale evaluations were under way but preliminary, and the March 2027 deadline might pass unmet. The heirs ran the house through its first founder-less year — direct-to-consumer sales up 3.5% even as wholesale fell — with EssilorLuxottica publicly warm and LVMH and L'Oréal waiting in the wings. The empire Armani refused to sell in life is being sold exactly as he instructed in death.